CpG island methylator phenotype in cancer (original) (raw)

• Jaenisch, R. & Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genet. 33 (Suppl.), 245–254 (2003).
  CAS PubMed Google Scholar
• Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21 (2002).
  CAS PubMed Google Scholar
• Li, E., Bestor, T. H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915–926 (1992).
  CAS PubMed Google Scholar
• Yoder, J. A., Walsh, C. P. & Bestor, T. H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13, 335–340 (1997).
  CAS PubMed Google Scholar
• Egger, G., Liang, G., Aparicio, A. & Jones, P. A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457–463 (2004).
  CAS PubMed Google Scholar
• Herman, J. G. & Baylin, S. B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349, 2042–2054 (2003).
  CAS PubMed Google Scholar
• Brinster, R. L. Participation of teratocarcinoma cells in mouse embryo development. Cancer Res. 36, 3412–3414 (1976).
  CAS PubMed Google Scholar
• Li, L., Connelly, M. C., Wetmore, C., Curran, T. & Morgan, J. I. Mouse embryos cloned from brain tumors. Cancer Res. 63, 2733–2736 (2003).
  CAS PubMed Google Scholar
• Hochedlinger, K. et al. Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev. 18, 1875–1885 (2004).
  CAS PubMed PubMed Central Google Scholar
• Santini, V., Kantarjian, H. M. & Issa, J. P. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann. Intern. Med. 134, 573–586 (2001).
  CAS PubMed Google Scholar
• Silverman, L. R. et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J. Clin. Oncol. 20, 2429–2440 (2002).
  CAS PubMed Google Scholar
• Jones, P. A. & Baylin, S. B. The fundamental role of epigenetic events in cancer. Nature Rev. Genet. 3, 415–428 (2002).
  CAS PubMed Google Scholar
• Sidransky, D. Emerging molecular markers of cancer. Nature Rev. Cancer 2, 210–219 (2002).
  CAS Google Scholar
• Issa, J. P. Methylation and prognosis: of molecular clocks and hypermethylator phenotypes. Clin. Cancer Res. 9, 2879–2881 (2003).
  CAS PubMed Google Scholar
• Issa, J. P. et al. Increased cytosine DNA-methyltransferase activity during colon cancer progression. J. Natl Cancer Inst. 85, 1235–1240 (1993).
  CAS PubMed Google Scholar
• De Marzo, A. M. et al. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res. 59, 3855–3860 (1999).
  CAS PubMed Google Scholar
• Robertson, K. D., Keyomarsi, K., Gonzales, F. A., Velicescu, M. & Jones, P. A. Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells. Nucleic Acids Res. 28, 2108–2113 (2000).
  CAS PubMed PubMed Central Google Scholar
• Eads, C. A. et al. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res. 59, 2302–2306 (1999).
  CAS PubMed Google Scholar
• Shen, L. et al. DNA methylation and environmental exposures in human hepatocellular carcinoma. J. Natl Cancer Inst. 94, 755–761 (2002).
  CAS PubMed Google Scholar
• Kim, D. H. et al. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res. 61, 3419–3424 (2001).
  CAS PubMed Google Scholar
• Issa, J. P., Baylin, S. B. & Belinsky, S. A. Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. Cancer Res. 56, 3655–3658 (1996).
  CAS PubMed Google Scholar
• Loeb, L. A. A mutator phenotype in cancer. Cancer Res. 61, 3230–3239 (2001).
  CAS PubMed Google Scholar
• Baylin, S. B. et al. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res. 46, 2917–2922 (1986).
  CAS PubMed Google Scholar
• Ahuja, N. et al. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res. 57, 3370–3374 (1997).
  CAS PubMed Google Scholar
• Kane, M. F. et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57, 808–811 (1997).
  CAS PubMed Google Scholar
• Herman, J. G. et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl Acad. Sci. USA 95, 6870–6875 (1998).
  CAS PubMed PubMed Central Google Scholar
• Shibata, D. M. et al. Hypermethylation of HPP1 is associated with hMLH1 hypermethylation in gastric adenocarcinomas. Cancer Res. 62, 5637–5640 (2002).
  CAS PubMed Google Scholar
• Shen, L., Kondo, Y., Hamilton, S. R., Rashid, A. & Issa, J. P. p14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53. Gastroenterology 124, 626–633 (2003).
  CAS PubMed Google Scholar
• Yamamoto, H. et al. Differential involvement of the hypermethylator phenotype in hereditary and sporadic colorectal cancers with high-frequency microsatellite instability. Genes Chromosomes Cancer 33, 322–325 (2002).
  CAS PubMed Google Scholar
• Toyota, M. et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 59, 2307–2312 (1999).
  CAS PubMed Google Scholar
• Toyota, M. et al. CpG Island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA 96, 8681–8686 (1999).
  CAS PubMed PubMed Central Google Scholar
• Issa, J. P. Epigenetic variation and human disease. J. Nutr. 132, 2388S–2392S (2002).
  CAS PubMed Google Scholar
• Issa, J. P. et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet. 7, 536–540 (1994).
  CAS PubMed Google Scholar
• Toyota, M., Ohe-Toyota, M., Ahuja, N. & Issa, J. P. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc. Natl Acad. Sci. USA 97, 710–715 (2000).
  CAS PubMed PubMed Central Google Scholar
• Kambara, T. et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53, 1137–1144 (2004).
  CAS PubMed PubMed Central Google Scholar
• Whitehall, V. L. et al. Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancer. Cancer Res. 62, 6011–6014 (2002).
  CAS PubMed Google Scholar
• Yan, P. S. et al. Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation. Methods 27, 162–169 (2002).
  CAS PubMed Google Scholar
• van Rijnsoever, M., Grieu, F., Elsaleh, H., Joseph, D. & Iacopetta, B. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 51, 797–802 (2002).
  CAS PubMed PubMed Central Google Scholar
• Li, Q. et al. Concordant methylation of the ER and N33 genes in glioblastoma multiforme. Oncogene 16, 3197–3202 (1998).
  CAS PubMed Google Scholar
• Toyota, M. et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 59, 5438–5442 (1999).
  CAS PubMed Google Scholar
• Kim, H. et al. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability. J. Pathol. 200, 23–31 (2003).
  CAS PubMed Google Scholar
• Ueki, T. et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res. 60, 1835–1839 (2000).
  CAS PubMed Google Scholar
• Strathdee, G. et al. Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am. J. Pathol. 158, 1121–1127 (2001).
  CAS PubMed PubMed Central Google Scholar
• Garcia-Manero, G. et al. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia. Clin. Cancer Res. 8, 2217–2224 (2002).
  CAS PubMed Google Scholar
• Toyota, M. et al. Methylation profiling in acute myeloid leukemia. Blood 97, 2823–2829 (2001).
  CAS PubMed Google Scholar
• Eads, C. A. et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 61, 3410–3418 (2001).
  CAS PubMed Google Scholar
• Yamashita, K., Dai, T., Dai, Y., Yamamoto, F. & Perucho, M. Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 4, 121–131 (2003).
  CAS PubMed Google Scholar
• Bestor, T. H. Unanswered questions about the role of promoter methylation in carcinogenesis. Ann. NY Acad. Sci. 983, 22–27 (2003).
  CAS PubMed Google Scholar
• Watanabe, T. et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N. Engl. J. Med. 344, 1196–1206 (2001).
  CAS PubMed PubMed Central Google Scholar
• Ward, R. L. et al. Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. J. Clin. Oncol. 21, 3729–3736 (2003).
  CAS PubMed Google Scholar
• Jass, J. R. Serrated route to colorectal cancer: back street or super highway? J. Pathol. 193, 283–285 (2001).
  CAS PubMed Google Scholar
• Chan, A. O., Issa, J. P., Morris, J. S., Hamilton, S. R. & Rashid, A. Concordant CpG island methylation in hyperplastic polyposis. Am. J. Pathol. 160, 529–536 (2002).
  CAS PubMed PubMed Central Google Scholar
• Park, S. J. et al. Frequent CpG island methylation in serrated adenomas of the colorectum. Am. J. Pathol. 162, 815–822 (2003).
  CAS PubMed PubMed Central Google Scholar
• Chan, T. L., Zhao, W., Leung, S. Y. & Yuen, S. T. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res. 63, 4878–4881 (2003).
  CAS PubMed Google Scholar
• Cunningham, J. M. et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 58, 3455–3460 (1998).
  CAS PubMed Google Scholar
• Ji, X., Woodard, A. S., Rimm, D. L. & Fearon, E. R. Transcriptional defects underlie loss of e-cadherin expression in breast cancer. Cell Growth Differ. 8, 773–778 (1997).
  CAS PubMed Google Scholar
• Song, J. Z., Stirzaker, C., Harrison, J., Melki, J. R. & Clark, S. J. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Oncogene 21, 1048–1061 (2002).
  CAS PubMed Google Scholar
• Toyota, M. et al. Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors. Cancer Res. 60, 4044–4048 (2000).
  CAS PubMed Google Scholar
• Issa, J. P. The epigenetics of colorectal cancer. Ann. NY Acad. Sci. 910, 140–153 (2000).
  CAS PubMed Google Scholar
• Turker, M. S. Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene 21, 5388–5393 (2002).
  CAS PubMed Google Scholar
• Velicescu, M. et al. Cell division is required for de novo methylation of CpG islands in bladder cancer cells. Cancer Res. 62, 2378–2384 (2002).
  CAS PubMed Google Scholar
• Kang, G. H. et al. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am. J. Pathol. 160, 787–794 (2002).
  CAS PubMed PubMed Central Google Scholar
• Waterland, R. A. & Jirtle, R. L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell Biol. 23, 5293–5300 (2003).
  CAS PubMed PubMed Central Google Scholar
• Issa, J. P., Ahuja, N., Toyota, M., Bronner, M. P. & Brentnall, T. A. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 61, 3573–3577 (2001).
  CAS PubMed Google Scholar
• Eads, C. A. et al. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res. 60, 5021–5026 (2000).
  CAS PubMed Google Scholar
• Zochbauer-Muller, S. et al. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res. 61, 249–255 (2001).
  CAS PubMed Google Scholar
• Fleisher, A. S. et al. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res. 60, 4864–4868 (2000).
  CAS PubMed Google Scholar
• Frazier, M. L. et al. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. Cancer Res. 63, 4805–4808 (2003).
  CAS PubMed Google Scholar
• Ricciardiello, L. et al. Frequent loss of hMLH1 by promoter hypermethylation leads to microsatellite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer. Cancer Res. 63, 787–792 (2003).
  CAS PubMed Google Scholar
• Laird, P. W. The power and the promise of DNA methylation markers. Nature Rev. Cancer 3, 253–266 (2003).
  CAS Google Scholar
• Leung, Y. F. & Cavalieri, D. Fundamentals of cDNA microarray data analysis. Trends Genet. 19, 649–659 (2003).
  CAS PubMed Google Scholar
• Kinzler, K. W. & Vogelstein, B. Lessons form hereditary colorectal cancer. Cell 87, 159–170 (1996).
  CAS PubMed Google Scholar
• Jass, J. R. Limitations of the adenoma-carcinoma sequence in colorectum. Clin. Cancer Res. 10, 5969–5970 (2004).
  CAS PubMed Google Scholar